A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children
Data Request Dashboard
NCT Number
Not Available
Data Specification
Not Available
Annotated CRF
Not Available
Product Info
Generic Name
Topiramate
Product Name
TOPAMAX®
Therapeutic Area
Nervous System Diseases
Enrollment
% Female
45.0%
% White
91.0%
Product Class
Anticonvulsants
Sponsor Protocol Number
YP
Data Partner
Johnson & Johnson
Condition Studied
Seizures
Mean/Median Age (Years)
9.0
Supporting Documentation
Clinical Study Report
Collected Datasets
Protocol with Amendments
Statistical Analysis Plan
APPROVED DATA REQUESTS ASSOCIATED WITH THIS TRIAL
Disclaimer
Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.